Member Info for Pingu777

Because Hemo is a minnow and hasn’t had a billion pounds from American government. There’ll be at least a thousand companies working on Covid. Can’t track them all.

It’s not Orgenesis, they’ve got a previously announced deal. They also have access to our mice as part of the original deal two years ago. GlobalCo signed a ‘mice development’ deal only in October 2019. And GlobalCo will be a multi-billion pound company, not a £120mcap junior (like a hemo will be on GlobalCo news)

DYOR.

GlobalCo will announce CDX human trials to commence.

CDX will be fine tuned to perfection and will be effective on attacking and removing AML as well as other cancers and blood diseases.

CDX results from phase one human testing will be mind blowing.

These announcements get closer every day and will arrive in July.

There’s only so long you can keep chasing rainbows elsewhere and expect to get back in here on the cheap.

DYOR.

Exactly Shaggy. HEMO will confirm, as Vlad says, that they’re a life saving company.

The announcement will confirm that human trials have been agreed and will begin soon. Then during those phase one trials results confirm it doesn’t show any signs of toxicity. Tick. But the results also demonstrate that a multiple of lives are saved as a result of the XDX treatment. This could be August or September. THIS WILL HAPPEN. What will the MCap be then?

Yes it’s a quarter away maybe but the value is now. As we get closer to GlobalCo it price will rise as this news, due to the magic of mice, is inevitable. It is not if, but when.

In my view the extension to the legal agreement started 30/4 and were nearly 2 months in. Therefore the agreement ends in July and the plethora of SP-blowing news begins.

People need to h set stand the magnitude of the news. It isn’t just who the GlobalCo is (but it will be big). It’s the AML cancer treatment that will remove the need for chemo which in itself is a treatment that doesn’t work most of the time on the disease. The update will confirm the features of CDX and it’s effectiveness and will change the face of treatment of Leukemia

The day of announcement gets ever closer. The share price will inevitably rocket on news. It will begin to build prior to the news on anticipation of this very fact. Many will miss out and chase it.

In the meantime sit tight investors. There’ll be lots of wittering on here. Trust your own reasoning. Hemo is firmly in its 12 months transformational period. 3 drugs to human trials and mice that will change the drug development world. Load up while the shares are cheap. This is the opportunity of a lifetime.

New@this. What is your point? We’re a junior pharma. Stuff takes a while to sort. Do you think cancer cures are developed over a lunch break and a coffee? Go mental and come back in a couple of months and tell me if people saying it will go higher than this are ramping?

Go proper mental and maybe read up on the company even?

So does my wife ... hmmm ...

New@this, just read some of your post history and you moan relentlessly. New@this, are you my wife?

It was also 2p pre £2.5m cash raise, pre GlobalCo delay, pre FINAL years end results and pre our Chairman’s recent award

Hi Charlie
Thanks for your response. I understand your strategy to trade momentum maybe. But playing pharma shares with short target timescales in mind is a risky business. The daily fluctuations at hemo can be big and since the GlobalCo announcement was effectively postponed then sentiment has dropped through the floor.

I would suggest that it would have been a good idea to assess what imminent newsflow you might expect and how it might affect the SP. Also did you target a particular piece of news?

I think what you’ll find on most BBs where you arrive, warn everyone of the risks of pharma plays, with minimal research under your belt and therefore no specific reason why you think your warning applies specifically to that company, then you’re gonna get a bit of stick. I have spent many many hours getting to grips with everything I can find to read about Hemo, it’s market space, staff cvs, Collabs, the actual tech.

Would you believe me if I said they have mice for pre-clinical testing, the IP for which I believe that on their own are worth nigh on our MCap and change the whole drug development industry? Mice tech!! It’s bonkers.

Sorry if I come across as patronising. But you need to read up on hemo if you’re concerned about it not being successful. Because you simply cannot know enough about them. And apologies for taking the P. Your money will return big rewards if you give Hemo time. I’d suggest 3 months will be transformational though a year is ideal.

DYOR.

Engage me Charlie... like an adult! Come on, give it a try?

Baseless opinions are frowned upon... by me at least.

Vitriol’s a bit steep Charlie. I took the P because has zero relevance to Hemo. Tell me why you invested? Or tell me why you think each of HEMOs products probably won’t reach commercials so we make money?

I didn’t say Hemo was on AIM ;-)

You could apply the ‘probably won’t succeed’ adage to most AIM companies. So why do we think Hemo is different? This is where research comes in.

Run me through your reasons for buying?

If Hemo drops to 3p I will become even more overweight in Hemo than I already am. DYOR.

Sorry Oz, I was being rather facetious. I am thankfully ultra confident in my Hemo position. In fact my 2yr old son laughed at Charlie’s post and said he knew more about Hemo than Charlie. (DHOTY).

Hang tough guys. Hemo have our years of work into our portfolio of products already and we are on the cusp now of HEMOs rise to stardom. Stay strong people.

Charlie’s right. My research is terrible and there’s no next step for Hemo to commercialise. It’s a just a void of nothingness. It’s all just a pipe dream.

I’ve put a sell order in for my shares tomorrow morning.

Thanks Charlie, I’m lucky I read your post before I lost it all.

This Board is a complete waste of time. Endless moaning and zero contributions about the company's projects or developments. Listen to Davie_b. The short term volatility can be a little frustrating but if you've got realistic investment timescales then your here for the newsflow we await and these dips are simply buying opportunities. If you need your capital back by Friday then you shouldn't be buying shares.

Mid 5s